Our global sites Open Search About us Our science Our products Investors Sustainability Careers Get in touch AIM rule 26 Allergy Therapeutics PLC AIM rule 26 Overview At a glance Financial highlights Investment case Regulatory news Email alert Results, reports and presentations Financial Calendar Share tools Shareholder services AIM Rule 26 Corporate governance Investor and Advisor Contacts This page enables investors and potential investors alike to access core management and financial information in compliance with Rule 26 of the AIM Rules for Companies. This information was last updated on 30 July 2021. For information on the following topics, please click on the links below. Description of the business Country of incorporation and operation Constitutional documents Details of any other exchanges or trading platforms Number of securities in issue Details of restrictions on transfer of securities Results, reports and presentations News and announcements Admission document and shareholder circulars Corporate governance code Director's detail Director's responsibilities and board committees UK city code on takeovers and mergers Nominated advisor Click for top of the page Linkedin icon Quick links Head office General inquiries Terms and Conditions Privacy Statement Cookies Adverse Event Reporting Modern Slavery and Human Trafficking Statement Gender Pay Gap QCA Code Compliance statement Contact us Allergy Therapeutics, Dominion Way, Worthing, West Sussex, BN14 8SA, United Kingdom Tel +44 (0)1903 844 700 © Allergy Therapeutics 2021. By Emperor Cookie Control

Cookie Control Our global sites Open Search About us Our science Our products Investors Sustainability Careers Get in touch Board of directors Allergy Therapeutics PLC Corporate governance Board of directors Overview At a glance Financial highlights Investment case Regulatory news Email alert Results, reports and presentations Financial Calendar Share tools Shareholder services AIM Rule 26 Corporate governance Board of directors Our board and its committees Investor and Advisor Contacts Peter Jensen Non-Executive Chairman Open more Scott Leinenweber Non-Executive Director Open more Manuel Llobet Chief Executive Officer Open more Cheryl MacDiarmid Cheryl MacDiarmid Open more Tunde Otulana Non-Executive Director Open more Mary Tavener Non-Executive Director Open more Nick Wykeman Chief Finance Officer Open more Click for top of the page Linkedin icon Quick links Head office General inquiries Terms and Conditions Privacy Statement Cookies Adverse Event Reporting Modern Slavery and Human Trafficking Statement Gender Pay Gap QCA Code Compliance statement Contact us Allergy Therapeutics, Dominion Way, Worthing, West Sussex, BN14 8SA, United Kingdom Tel +44 (0)1903 844 700 © Allergy Therapeutics 2021. By Emperor